nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.105	0.403	CbGbCtD
Granisetron—CYP2D6—Captopril—systemic scleroderma	0.0816	0.314	CbGbCtD
Granisetron—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0409	0.157	CbGbCtD
Granisetron—CYP3A4—Prednisone—systemic scleroderma	0.0327	0.126	CbGbCtD
Granisetron—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0318	0.723	CbGeAlD
Granisetron—HTR3A—digestive system—systemic scleroderma	0.00241	0.0547	CbGeAlD
Granisetron—HTR3A—lung—systemic scleroderma	0.00201	0.0457	CbGeAlD
Granisetron—CYP1A1—skin of body—systemic scleroderma	0.00153	0.0348	CbGeAlD
Granisetron—CYP1A1—digestive system—systemic scleroderma	0.00123	0.0279	CbGeAlD
Granisetron—CYP3A5—digestive system—systemic scleroderma	0.0012	0.0272	CbGeAlD
Granisetron—CYP1A1—lung—systemic scleroderma	0.00102	0.0233	CbGeAlD
Granisetron—CYP3A5—lung—systemic scleroderma	0.001	0.0228	CbGeAlD
Granisetron—CYP3A4—digestive system—systemic scleroderma	0.0009	0.0204	CbGeAlD
Granisetron—CYP2D6—digestive system—systemic scleroderma	0.000886	0.0201	CbGeAlD
Granisetron—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000784	0.00113	CcSEcCtD
Granisetron—Headache—Mometasone—systemic scleroderma	0.000783	0.00113	CcSEcCtD
Granisetron—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000782	0.00112	CcSEcCtD
Granisetron—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000781	0.00112	CcSEcCtD
Granisetron—Insomnia—Mycophenolic acid—systemic scleroderma	0.000781	0.00112	CcSEcCtD
Granisetron—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000778	0.00112	CcSEcCtD
Granisetron—Oedema—Lisinopril—systemic scleroderma	0.000778	0.00112	CcSEcCtD
Granisetron—Pruritus—Captopril—systemic scleroderma	0.000777	0.00112	CcSEcCtD
Granisetron—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000775	0.00111	CcSEcCtD
Granisetron—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000775	0.00111	CcSEcCtD
Granisetron—Constipation—Leflunomide—systemic scleroderma	0.000774	0.00111	CcSEcCtD
Granisetron—Pain—Leflunomide—systemic scleroderma	0.000774	0.00111	CcSEcCtD
Granisetron—Infection—Lisinopril—systemic scleroderma	0.000773	0.00111	CcSEcCtD
Granisetron—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000772	0.00111	CcSEcCtD
Granisetron—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00077	0.00111	CcSEcCtD
Granisetron—Somnolence—Mycophenolic acid—systemic scleroderma	0.000768	0.0011	CcSEcCtD
Granisetron—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000767	0.0011	CcSEcCtD
Granisetron—Shock—Lisinopril—systemic scleroderma	0.000765	0.0011	CcSEcCtD
Granisetron—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000762	0.00109	CcSEcCtD
Granisetron—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00076	0.00109	CcSEcCtD
Granisetron—Tachycardia—Lisinopril—systemic scleroderma	0.000759	0.00109	CcSEcCtD
Granisetron—Abdominal pain—Azathioprine—systemic scleroderma	0.000758	0.00109	CcSEcCtD
Granisetron—Body temperature increased—Azathioprine—systemic scleroderma	0.000758	0.00109	CcSEcCtD
Granisetron—Skin disorder—Lisinopril—systemic scleroderma	0.000756	0.00109	CcSEcCtD
Granisetron—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000753	0.00108	CcSEcCtD
Granisetron—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000752	0.00108	CcSEcCtD
Granisetron—Diarrhoea—Captopril—systemic scleroderma	0.000751	0.00108	CcSEcCtD
Granisetron—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000751	0.00108	CcSEcCtD
Granisetron—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00075	0.00108	CcSEcCtD
Granisetron—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000749	0.00108	CcSEcCtD
Granisetron—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000747	0.00107	CcSEcCtD
Granisetron—Feeling abnormal—Leflunomide—systemic scleroderma	0.000746	0.00107	CcSEcCtD
Granisetron—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000746	0.00107	CcSEcCtD
Granisetron—Nausea—Mometasone—systemic scleroderma	0.000743	0.00107	CcSEcCtD
Granisetron—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00074	0.00106	CcSEcCtD
Granisetron—Pain—Mycophenolic acid—systemic scleroderma	0.000738	0.00106	CcSEcCtD
Granisetron—Constipation—Mycophenolic acid—systemic scleroderma	0.000738	0.00106	CcSEcCtD
Granisetron—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000738	0.00106	CcSEcCtD
Granisetron—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000734	0.00105	CcSEcCtD
Granisetron—Cough—Mycophenolate mofetil—systemic scleroderma	0.000729	0.00105	CcSEcCtD
Granisetron—Hypotension—Lisinopril—systemic scleroderma	0.000727	0.00104	CcSEcCtD
Granisetron—Dizziness—Captopril—systemic scleroderma	0.000726	0.00104	CcSEcCtD
Granisetron—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000725	0.00104	CcSEcCtD
Granisetron—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000721	0.00104	CcSEcCtD
Granisetron—Urticaria—Leflunomide—systemic scleroderma	0.000719	0.00103	CcSEcCtD
Granisetron—Abdominal pain—Leflunomide—systemic scleroderma	0.000716	0.00103	CcSEcCtD
Granisetron—Body temperature increased—Leflunomide—systemic scleroderma	0.000716	0.00103	CcSEcCtD
Granisetron—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000712	0.00102	CcSEcCtD
Granisetron—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000711	0.00102	CcSEcCtD
Granisetron—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000711	0.00102	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000709	0.00102	CcSEcCtD
Granisetron—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000708	0.00102	CcSEcCtD
Granisetron—Hypersensitivity—Azathioprine—systemic scleroderma	0.000706	0.00101	CcSEcCtD
Granisetron—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000706	0.00101	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000706	0.00101	CcSEcCtD
Granisetron—Insomnia—Lisinopril—systemic scleroderma	0.000703	0.00101	CcSEcCtD
Granisetron—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00101	CcSEcCtD
Granisetron—Paraesthesia—Lisinopril—systemic scleroderma	0.000698	0.001	CcSEcCtD
Granisetron—Vomiting—Captopril—systemic scleroderma	0.000698	0.001	CcSEcCtD
Granisetron—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000695	0.000999	CcSEcCtD
Granisetron—Dyspnoea—Lisinopril—systemic scleroderma	0.000693	0.000996	CcSEcCtD
Granisetron—Rash—Captopril—systemic scleroderma	0.000693	0.000995	CcSEcCtD
Granisetron—Dermatitis—Captopril—systemic scleroderma	0.000692	0.000994	CcSEcCtD
Granisetron—Somnolence—Lisinopril—systemic scleroderma	0.000691	0.000993	CcSEcCtD
Granisetron—Headache—Captopril—systemic scleroderma	0.000688	0.000988	CcSEcCtD
Granisetron—Dyspepsia—Lisinopril—systemic scleroderma	0.000685	0.000984	CcSEcCtD
Granisetron—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000683	0.000981	CcSEcCtD
Granisetron—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000683	0.000981	CcSEcCtD
Granisetron—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000681	0.000979	CcSEcCtD
Granisetron—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000681	0.000979	CcSEcCtD
Granisetron—Infection—Mycophenolate mofetil—systemic scleroderma	0.000677	0.000973	CcSEcCtD
Granisetron—Decreased appetite—Lisinopril—systemic scleroderma	0.000676	0.000971	CcSEcCtD
Granisetron—Eosinophilia—Methotrexate—systemic scleroderma	0.000672	0.000966	CcSEcCtD
Granisetron—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000672	0.000965	CcSEcCtD
Granisetron—Shock—Mycophenolate mofetil—systemic scleroderma	0.00067	0.000963	CcSEcCtD
Granisetron—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000668	0.00096	CcSEcCtD
Granisetron—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000667	0.000959	CcSEcCtD
Granisetron—Hypersensitivity—Leflunomide—systemic scleroderma	0.000667	0.000958	CcSEcCtD
Granisetron—Pain—Lisinopril—systemic scleroderma	0.000665	0.000955	CcSEcCtD
Granisetron—Constipation—Lisinopril—systemic scleroderma	0.000665	0.000955	CcSEcCtD
Granisetron—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000665	0.000955	CcSEcCtD
Granisetron—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000662	0.000951	CcSEcCtD
Granisetron—Bradycardia—Prednisone—systemic scleroderma	0.000662	0.000951	CcSEcCtD
Granisetron—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000659	0.000946	CcSEcCtD
Granisetron—Diarrhoea—Azathioprine—systemic scleroderma	0.000656	0.000942	CcSEcCtD
Granisetron—Nausea—Captopril—systemic scleroderma	0.000652	0.000937	CcSEcCtD
Granisetron—Asthenia—Leflunomide—systemic scleroderma	0.000649	0.000933	CcSEcCtD
Granisetron—Feeling abnormal—Lisinopril—systemic scleroderma	0.000641	0.000921	CcSEcCtD
Granisetron—Pruritus—Leflunomide—systemic scleroderma	0.00064	0.00092	CcSEcCtD
Granisetron—Connective tissue disorder—Prednisone—systemic scleroderma	0.000639	0.000918	CcSEcCtD
Granisetron—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000637	0.000915	CcSEcCtD
Granisetron—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000636	0.000914	CcSEcCtD
Granisetron—Dysuria—Methotrexate—systemic scleroderma	0.000635	0.000912	CcSEcCtD
Granisetron—Dizziness—Azathioprine—systemic scleroderma	0.000634	0.000911	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000621	0.000892	CcSEcCtD
Granisetron—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00062	0.00089	CcSEcCtD
Granisetron—Asthenia—Mycophenolic acid—systemic scleroderma	0.00062	0.00089	CcSEcCtD
Granisetron—Diarrhoea—Leflunomide—systemic scleroderma	0.000619	0.00089	CcSEcCtD
Granisetron—Urticaria—Lisinopril—systemic scleroderma	0.000618	0.000888	CcSEcCtD
Granisetron—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000616	0.000885	CcSEcCtD
Granisetron—Body temperature increased—Lisinopril—systemic scleroderma	0.000615	0.000883	CcSEcCtD
Granisetron—Abdominal pain—Lisinopril—systemic scleroderma	0.000615	0.000883	CcSEcCtD
Granisetron—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000612	0.000879	CcSEcCtD
Granisetron—Pruritus—Mycophenolic acid—systemic scleroderma	0.000611	0.000878	CcSEcCtD
Granisetron—Vomiting—Azathioprine—systemic scleroderma	0.000609	0.000875	CcSEcCtD
Granisetron—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000608	0.000873	CcSEcCtD
Granisetron—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000606	0.00087	CcSEcCtD
Granisetron—Rash—Azathioprine—systemic scleroderma	0.000604	0.000868	CcSEcCtD
Granisetron—Dermatitis—Azathioprine—systemic scleroderma	0.000604	0.000867	CcSEcCtD
Granisetron—Flushing—Prednisone—systemic scleroderma	0.000603	0.000867	CcSEcCtD
Granisetron—Headache—Azathioprine—systemic scleroderma	0.0006	0.000863	CcSEcCtD
Granisetron—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.0006	0.000862	CcSEcCtD
Granisetron—Dizziness—Leflunomide—systemic scleroderma	0.000599	0.00086	CcSEcCtD
Granisetron—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000592	0.000851	CcSEcCtD
Granisetron—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000591	0.000849	CcSEcCtD
Granisetron—Angiopathy—Prednisone—systemic scleroderma	0.00059	0.000847	CcSEcCtD
Granisetron—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000588	0.000845	CcSEcCtD
Granisetron—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000583	0.000837	CcSEcCtD
Granisetron—Pain—Mycophenolate mofetil—systemic scleroderma	0.000583	0.000837	CcSEcCtD
Granisetron—Arrhythmia—Prednisone—systemic scleroderma	0.000581	0.000834	CcSEcCtD
Granisetron—Sweating—Methotrexate—systemic scleroderma	0.00058	0.000834	CcSEcCtD
Granisetron—Vomiting—Leflunomide—systemic scleroderma	0.000576	0.000827	CcSEcCtD
Granisetron—Alopecia—Prednisone—systemic scleroderma	0.000575	0.000825	CcSEcCtD
Granisetron—Hypersensitivity—Lisinopril—systemic scleroderma	0.000573	0.000823	CcSEcCtD
Granisetron—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000572	0.000822	CcSEcCtD
Granisetron—Dizziness—Mycophenolic acid—systemic scleroderma	0.000571	0.00082	CcSEcCtD
Granisetron—Epistaxis—Methotrexate—systemic scleroderma	0.000571	0.00082	CcSEcCtD
Granisetron—Rash—Leflunomide—systemic scleroderma	0.000571	0.00082	CcSEcCtD
Granisetron—Dermatitis—Leflunomide—systemic scleroderma	0.00057	0.000819	CcSEcCtD
Granisetron—Nausea—Azathioprine—systemic scleroderma	0.000569	0.000818	CcSEcCtD
Granisetron—Headache—Leflunomide—systemic scleroderma	0.000567	0.000815	CcSEcCtD
Granisetron—Malnutrition—Prednisone—systemic scleroderma	0.000566	0.000813	CcSEcCtD
Granisetron—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000562	0.000807	CcSEcCtD
Granisetron—Asthenia—Lisinopril—systemic scleroderma	0.000558	0.000802	CcSEcCtD
Granisetron—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000557	0.000801	CcSEcCtD
Granisetron—Pruritus—Lisinopril—systemic scleroderma	0.00055	0.000791	CcSEcCtD
Granisetron—Vomiting—Mycophenolic acid—systemic scleroderma	0.000549	0.000789	CcSEcCtD
Granisetron—Rash—Mycophenolic acid—systemic scleroderma	0.000544	0.000782	CcSEcCtD
Granisetron—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000544	0.000781	CcSEcCtD
Granisetron—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000541	0.000778	CcSEcCtD
Granisetron—Headache—Mycophenolic acid—systemic scleroderma	0.000541	0.000777	CcSEcCtD
Granisetron—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000539	0.000774	CcSEcCtD
Granisetron—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000539	0.000774	CcSEcCtD
Granisetron—Nausea—Leflunomide—systemic scleroderma	0.000538	0.000772	CcSEcCtD
Granisetron—Diarrhoea—Lisinopril—systemic scleroderma	0.000532	0.000764	CcSEcCtD
Granisetron—Ill-defined disorder—Prednisone—systemic scleroderma	0.000525	0.000754	CcSEcCtD
Granisetron—Visual impairment—Methotrexate—systemic scleroderma	0.000524	0.000752	CcSEcCtD
Granisetron—Anaemia—Prednisone—systemic scleroderma	0.000523	0.000752	CcSEcCtD
Granisetron—Agitation—Prednisone—systemic scleroderma	0.00052	0.000747	CcSEcCtD
Granisetron—Dizziness—Lisinopril—systemic scleroderma	0.000514	0.000739	CcSEcCtD
Granisetron—Nausea—Mycophenolic acid—systemic scleroderma	0.000513	0.000737	CcSEcCtD
Granisetron—Malaise—Prednisone—systemic scleroderma	0.00051	0.000733	CcSEcCtD
Granisetron—Vertigo—Prednisone—systemic scleroderma	0.000509	0.000731	CcSEcCtD
Granisetron—Syncope—Prednisone—systemic scleroderma	0.000508	0.000729	CcSEcCtD
Granisetron—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000502	0.000721	CcSEcCtD
Granisetron—Loss of consciousness—Prednisone—systemic scleroderma	0.000497	0.000715	CcSEcCtD
Granisetron—Vomiting—Lisinopril—systemic scleroderma	0.000495	0.00071	CcSEcCtD
Granisetron—Angiopathy—Methotrexate—systemic scleroderma	0.000493	0.000708	CcSEcCtD
Granisetron—Rash—Lisinopril—systemic scleroderma	0.00049	0.000704	CcSEcCtD
Granisetron—Dermatitis—Lisinopril—systemic scleroderma	0.00049	0.000704	CcSEcCtD
Granisetron—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000489	0.000702	CcSEcCtD
Granisetron—Hypertension—Prednisone—systemic scleroderma	0.000489	0.000702	CcSEcCtD
Granisetron—Chills—Methotrexate—systemic scleroderma	0.000488	0.0007	CcSEcCtD
Granisetron—Headache—Lisinopril—systemic scleroderma	0.000487	0.0007	CcSEcCtD
Granisetron—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000482	0.000693	CcSEcCtD
Granisetron—Arthralgia—Prednisone—systemic scleroderma	0.000482	0.000692	CcSEcCtD
Granisetron—Anxiety—Prednisone—systemic scleroderma	0.00048	0.00069	CcSEcCtD
Granisetron—Alopecia—Methotrexate—systemic scleroderma	0.00048	0.00069	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000479	0.000687	CcSEcCtD
Granisetron—Discomfort—Prednisone—systemic scleroderma	0.000476	0.000684	CcSEcCtD
Granisetron—Malnutrition—Methotrexate—systemic scleroderma	0.000473	0.00068	CcSEcCtD
Granisetron—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000466	0.00067	CcSEcCtD
Granisetron—Dysgeusia—Methotrexate—systemic scleroderma	0.000463	0.000665	CcSEcCtD
Granisetron—Nausea—Lisinopril—systemic scleroderma	0.000462	0.000664	CcSEcCtD
Granisetron—Anaphylactic shock—Prednisone—systemic scleroderma	0.000462	0.000664	CcSEcCtD
Granisetron—Oedema—Prednisone—systemic scleroderma	0.000462	0.000664	CcSEcCtD
Granisetron—Infection—Prednisone—systemic scleroderma	0.000459	0.000659	CcSEcCtD
Granisetron—Shock—Prednisone—systemic scleroderma	0.000454	0.000653	CcSEcCtD
Granisetron—Nervous system disorder—Prednisone—systemic scleroderma	0.000453	0.000651	CcSEcCtD
Granisetron—Tachycardia—Prednisone—systemic scleroderma	0.000451	0.000648	CcSEcCtD
Granisetron—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000451	0.000647	CcSEcCtD
Granisetron—Skin disorder—Prednisone—systemic scleroderma	0.000449	0.000645	CcSEcCtD
Granisetron—Hyperhidrosis—Prednisone—systemic scleroderma	0.000447	0.000642	CcSEcCtD
Granisetron—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000439	0.00063	CcSEcCtD
Granisetron—Anaemia—Methotrexate—systemic scleroderma	0.000437	0.000628	CcSEcCtD
Granisetron—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000433	0.000622	CcSEcCtD
Granisetron—Rash—Mycophenolate mofetil—systemic scleroderma	0.00043	0.000617	CcSEcCtD
Granisetron—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000429	0.000617	CcSEcCtD
Granisetron—Headache—Mycophenolate mofetil—systemic scleroderma	0.000427	0.000613	CcSEcCtD
Granisetron—Malaise—Methotrexate—systemic scleroderma	0.000427	0.000613	CcSEcCtD
Granisetron—Vertigo—Methotrexate—systemic scleroderma	0.000425	0.000611	CcSEcCtD
Granisetron—Leukopenia—Methotrexate—systemic scleroderma	0.000423	0.000608	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000421	0.000605	CcSEcCtD
Granisetron—Insomnia—Prednisone—systemic scleroderma	0.000418	0.0006	CcSEcCtD
Granisetron—Paraesthesia—Prednisone—systemic scleroderma	0.000415	0.000596	CcSEcCtD
Granisetron—Cough—Methotrexate—systemic scleroderma	0.000413	0.000593	CcSEcCtD
Granisetron—Dyspepsia—Prednisone—systemic scleroderma	0.000407	0.000584	CcSEcCtD
Granisetron—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000405	0.000581	CcSEcCtD
Granisetron—Arthralgia—Methotrexate—systemic scleroderma	0.000403	0.000579	CcSEcCtD
Granisetron—Chest pain—Methotrexate—systemic scleroderma	0.000403	0.000579	CcSEcCtD
Granisetron—Decreased appetite—Prednisone—systemic scleroderma	0.000402	0.000577	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.0004	0.000575	CcSEcCtD
Granisetron—Discomfort—Methotrexate—systemic scleroderma	0.000398	0.000572	CcSEcCtD
Granisetron—Constipation—Prednisone—systemic scleroderma	0.000395	0.000567	CcSEcCtD
Granisetron—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000386	0.000555	CcSEcCtD
Granisetron—Infection—Methotrexate—systemic scleroderma	0.000384	0.000551	CcSEcCtD
Granisetron—Feeling abnormal—Prednisone—systemic scleroderma	0.000381	0.000547	CcSEcCtD
Granisetron—Nervous system disorder—Methotrexate—systemic scleroderma	0.000379	0.000544	CcSEcCtD
Granisetron—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000378	0.000543	CcSEcCtD
Granisetron—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000378	0.000543	CcSEcCtD
Granisetron—Skin disorder—Methotrexate—systemic scleroderma	0.000375	0.000539	CcSEcCtD
Granisetron—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000373	0.000536	CcSEcCtD
Granisetron—Urticaria—Prednisone—systemic scleroderma	0.000367	0.000527	CcSEcCtD
Granisetron—Body temperature increased—Prednisone—systemic scleroderma	0.000365	0.000525	CcSEcCtD
Granisetron—Abdominal pain—Prednisone—systemic scleroderma	0.000365	0.000525	CcSEcCtD
Granisetron—Hypotension—Methotrexate—systemic scleroderma	0.000361	0.000518	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000352	0.000505	CcSEcCtD
Granisetron—Insomnia—Methotrexate—systemic scleroderma	0.000349	0.000502	CcSEcCtD
Granisetron—Paraesthesia—Methotrexate—systemic scleroderma	0.000347	0.000498	CcSEcCtD
Granisetron—Dyspnoea—Methotrexate—systemic scleroderma	0.000344	0.000494	CcSEcCtD
Granisetron—Somnolence—Methotrexate—systemic scleroderma	0.000343	0.000493	CcSEcCtD
Granisetron—Hypersensitivity—Prednisone—systemic scleroderma	0.00034	0.000489	CcSEcCtD
Granisetron—Dyspepsia—Methotrexate—systemic scleroderma	0.00034	0.000488	CcSEcCtD
Granisetron—Decreased appetite—Methotrexate—systemic scleroderma	0.000336	0.000482	CcSEcCtD
Granisetron—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000333	0.000479	CcSEcCtD
Granisetron—Asthenia—Prednisone—systemic scleroderma	0.000331	0.000476	CcSEcCtD
Granisetron—Pain—Methotrexate—systemic scleroderma	0.00033	0.000474	CcSEcCtD
Granisetron—Pruritus—Prednisone—systemic scleroderma	0.000327	0.000469	CcSEcCtD
Granisetron—Feeling abnormal—Methotrexate—systemic scleroderma	0.000318	0.000457	CcSEcCtD
Granisetron—Diarrhoea—Prednisone—systemic scleroderma	0.000316	0.000454	CcSEcCtD
Granisetron—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000316	0.000453	CcSEcCtD
Granisetron—Urticaria—Methotrexate—systemic scleroderma	0.000307	0.000441	CcSEcCtD
Granisetron—Dizziness—Prednisone—systemic scleroderma	0.000305	0.000439	CcSEcCtD
Granisetron—Body temperature increased—Methotrexate—systemic scleroderma	0.000305	0.000438	CcSEcCtD
Granisetron—Abdominal pain—Methotrexate—systemic scleroderma	0.000305	0.000438	CcSEcCtD
Granisetron—Vomiting—Prednisone—systemic scleroderma	0.000294	0.000422	CcSEcCtD
Granisetron—Rash—Prednisone—systemic scleroderma	0.000291	0.000418	CcSEcCtD
Granisetron—Dermatitis—Prednisone—systemic scleroderma	0.000291	0.000418	CcSEcCtD
Granisetron—Headache—Prednisone—systemic scleroderma	0.000289	0.000416	CcSEcCtD
Granisetron—Hypersensitivity—Methotrexate—systemic scleroderma	0.000284	0.000409	CcSEcCtD
Granisetron—Asthenia—Methotrexate—systemic scleroderma	0.000277	0.000398	CcSEcCtD
Granisetron—Nausea—Prednisone—systemic scleroderma	0.000274	0.000394	CcSEcCtD
Granisetron—Pruritus—Methotrexate—systemic scleroderma	0.000273	0.000392	CcSEcCtD
Granisetron—Diarrhoea—Methotrexate—systemic scleroderma	0.000264	0.000379	CcSEcCtD
Granisetron—Dizziness—Methotrexate—systemic scleroderma	0.000255	0.000367	CcSEcCtD
Granisetron—Vomiting—Methotrexate—systemic scleroderma	0.000245	0.000353	CcSEcCtD
Granisetron—Rash—Methotrexate—systemic scleroderma	0.000243	0.00035	CcSEcCtD
Granisetron—Dermatitis—Methotrexate—systemic scleroderma	0.000243	0.000349	CcSEcCtD
Granisetron—Headache—Methotrexate—systemic scleroderma	0.000242	0.000347	CcSEcCtD
Granisetron—Nausea—Methotrexate—systemic scleroderma	0.000229	0.000329	CcSEcCtD
